(2) Temporal Trends in ADR prevalence As illustrated in Figure 1 , the annual ADR prevalence showed an increasing trend from 2014 to 2023, rising from 0.5% (95% CI, 0.4–0.6%) in 2014 to 1.1% (95% CI, 1.0–1.2%) in 2023, with slight fluctuations in 2016, 2020, and 2022.
← all excerpts
Adverse Reactions to CT Contrast Agents: A 10-Year Study of Clinical and Environmental Risk Factors.
2
—
—
The sentences
In contrast, the prevalence of moderate ADRs showed a decreasing trend starting from the pandemic period.